23andMe Independent Directors Resign Amid Clash With CEO Over Buyout Proposal

Dow Jones
2024-09-18
 

By Sabela Ojea

 

The independent directors of 23andMe have resigned, citing lack of an actionable proposal for non-affiliated shareholders as Chief Executive Anne Wojcicki seeks to take the company private.

Seven independent directors of the DNA-testing company's board on Tuesday sent a letter to Wojcicki explaining their resignation. They said they also differed on the strategic direction for the company going forward.

"After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders," the directors said. "That we have not seen any notable progress over the last 5 months leads us to believe no such proposal is forthcoming."

Roelof Botha, Patrick Chung, Sandra Hernández, Neal Mohan, together with Valerie Montgomery Rice, Richard Scheller and Peter Taylor, were 23andMe's independent board directors.

23andMe made public in April that Wojcicki was seeking to take it private after three years in public markets that saw the company's once-hot valuation collapse from a high of $6 billion to around $170 million.

Last month, 23andMe said it received a preliminary non-binding indication of interest from Wojcicki to acquire all of the outstanding shares of 23andMe not owned by her or her affiliates or any other stockholder that she invites to roll over their shares for a cash consideration of 40 cents per share.

A day later, the special committee of the board showed opposition to the proposal and said it was disappointed with the proposal for multiple reasons, including because it provided no premium to the closing price per share on July 31, it lacked committed financing, and it was conditional in nature.

"Importantly, we request that you immediately withdraw your stated intent to oppose any alternative transaction so that we can fully assess whether there is interest from third parties in a transaction that would maximize value for all shareholders," they said.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

September 17, 2024 17:15 ET (21:15 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10